Also trades as: POLB.L (LSE) · $vol 0M
POLBF OTC
Poolbeg Pharma PLC
1W: +0.0%
1M: +0.0%
3M: +0.8%
YTD: +125.4%
1Y: +125.4%
3Y: +23.8%
$0.10
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+100.0% ▲
Operating Income
-$6M
-26.5% ▼
Net Income
-$6M
-47.3% ▼
EPS (Diluted)
$-0.01
-46.8% ▼
EBITDA
-$6M
-28.7% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $18K | $26K | $26K | $0 |
| Gross Profit | -$18K | -$26K | -$26K | $0 |
| Gross Margin | — | — | — | — |
| R&D Expenses | $414K | $2M | $2M | $1M |
| SG&A Expenses | $2M | $3M | $3M | $5M |
| Operating Expenses | $3M | $5M | $5M | $6M |
| Operating Income | -$3M | -$5M | -$5M | -$6M |
| Operating Margin | — | — | — | — |
| Interest Expense | $0 | $0 | $0 | $0 |
| Income Before Tax | -$2M | -$5M | -$5M | -$6M |
| Tax Expense | $0 | -$91K | -$574K | $154K |
| Net Income | -$2M | -$5M | -$4M | -$6M |
| Net Margin | — | — | — | — |
| EPS (Diluted) | $-0.01 | $-0.01 | $-0.01 | $-0.01 |
| EBITDA | -$3M | -$5M | -$5M | -$6M |
| Shares Outstanding | 317M | 500M | 500M | 500M |